Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Grifols (GRFS)

  • Event
  • Oct. 21, 2022, 21:10 UTC
  • 10
  • 1 comments

(99% Neutral) Grifols (GRFS) Files Form 6-K

Comment Full text

Amarin Corporation Plc (AMRN)

  • Event
  • Oct. 21, 2022, 21:06 UTC
  • 14
  • 1 comments

(99% Neutral) AMARIN CORP PLC\UK (AMRN) Announces Business Combination

Comment Full text

Urogen Pharma Inc (URGN)

  • Event
  • Oct. 21, 2022, 20:05 UTC
  • 14
  • 1 comments

(99% Neutral) UROGEN PHARMA LTD. (URGN) Announces Business Combination

Comment Full text

Pfizer Inc (PFE)

  • Event
  • Oct. 21, 2022, 16:34 UTC
  • 89
  • 0 comments

Pfizer Inc. - Pfizer Analyst and Investor Call to Review RSV Data Presented at ID Week 2022

Comment Full text

Silverback Therapeutics Inc (company was transformed to ARS Pharmaceuticals (NASDAQ : SPRY) (SBTX)

  • Event
  • Oct. 21, 2022, 11:36 UTC
  • 12
  • 1 comments

(10% Negative) SILVERBACK THERAPEUTICS, INC. (SBTX) Announces Delay in anaphylaxis Trials for review ARS Pharmaceuticals Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

Comment Full text

Mereo BioPharma (MREO)

  • Event
  • Oct. 21, 2022, 11:06 UTC
  • 5
  • 1 comments

(99% Neutral) Mereo BioPharma (MREO) Announces 2022 Annual General Meeting

Comment Full text

Aurinia Pharmaceuticals Inc (AUPH)

  • Event
  • Oct. 21, 2022, 10:12 UTC
  • 12
  • 1 comments

(99% Neutral) Aurinia Pharmaceuticals Inc. (AUPH) Announces Executive Departure

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Oct. 21, 2022, 10:09 UTC
  • 6
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

Ironwood Pharmaceuticals Inc (IRWD)

  • Event
  • Oct. 20, 2022, 14:02 UTC
  • 91
  • 0 comments

Ironwood - Ironwood Pharmaceuticals Q3 2022 Investor Update Conference Call

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Oct. 20, 2022, 14:00 UTC
  • 90
  • 0 comments

Cytokinetics to Announce Third Quarter Results on November 3, 2022

Comment Full text
  • Previous
  • 21
  • 22
  • 23
  • 24
  • 25
  • Next

Search

News categories

  • Technical Exchange News(10320)
  • Event(1442)
  • SEC News(175250)
  • FDA Approval(9644)
  • Company Report(721)
  • Business News(117525)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin